Cutler Group LP Ironwood Pharmaceuticals Inc Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 27, 2020	SELL	$8.99 - $10.74 $47,647 - $56,922	-5,300 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$9.14 - $11.97 $914 - $1,197	100 Added 1.92%	5,300 $54,000
Q1 2020 May 07, 2020	BUY	$8.58 - $14.01 $44,616 - $72,852	5,200 New	5,200 $52,000
Q4 2018 Feb 05, 2019	SELL	$7.8 - $16.13 $2,106 - $4,355	-270 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$14.31 - $17.65 $4,293 - $5,295	-300 Reduced 52.63%	270 $4,000
Q2 2018 Aug 10, 2018	BUY	$11.83 - $16.2 $6,743 - $9,234	570 New	570 $10,000

232

163M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $323M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.